Virus expression and immunoprophylaxis of a murine lymphoma
- PMID: 164567
Virus expression and immunoprophylaxis of a murine lymphoma
Abstract
CBA mice tested with a rapidly lethal transplanted lymphoma could survive challenge when pretreated with allogeneic lymphoma cells or other material expressing murine leukemia virus (MuLV). Protection resulted when recipients were given injections of AKR and C3H transplanted lymphomas or selected normal AKR and SJL tissues, filtrates of which give positive assays for MuLV by in vitro and/or in vivo tests. There was no protection when recipients were given injections of C3H lymphomas or C3H normal tissues that failed to have positive assays for virus.
Similar articles
-
Virion interaction in mouse lymphomas.Cancer Res. 1976 Feb;36(2 Pt 1):370-4. Cancer Res. 1976. PMID: 177196
-
A discrepancy in XC and oncogenicity assays for murine leukemia virus in AKR mice.Cancer Res. 1977 Mar;37(3):726-30. Cancer Res. 1977. PMID: 189912
-
Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.Cancer Res. 1985 Dec;45(12 Pt 1):6428-35. Cancer Res. 1985. PMID: 2998600
-
Development of tumors as a result of graft-versus-host reaction.Exp Hematol. 1973;1(3):135-49. Exp Hematol. 1973. PMID: 4153858 Review. No abstract available.
-
Mouse leukemia and solid tumors treated with bone marrow grafting.Transplant Proc. 1976 Dec;8(4):565-7. Transplant Proc. 1976. PMID: 11588 Review. No abstract available.